Nogueira M - Search Results

1

[Telemedicine in neurodevelopmental pediatrics during the COVID-19 pandemic: experience of a tertiary hospital].

Nogueira M, Vale-Lima R, Silva C, Gonçalves D, Guardiano M. Nogueira M, et al. Rev Neurol. 2020 Dec 16;71(12):467-468. doi: 10.33588/rn.7112.2020554. Rev Neurol. 2020. PMID: 33319350 Free article. Spanish.

2

PURA syndrome in a child with severe developmental delay: a challenging diagnosis.

Nogueira M, Melo C, Grangeia A, Magalhães T, Soares C, Dias R, Fonseca J, Sampaio M, Sousa R. Nogueira M, et al. Rev Neurol. 2022 Mar 1;74(5):170-173. doi: 10.33588/rn.7405.2021068. Rev Neurol. 2022. PMID: 35211951 Free PMC article. English, Spanish.

3

The Importance of Patch Testing in Anogenital Dermatitis: Ten-Year Experience of a Tertiary Referral Center in Northern Portugal.

Reis J, Marques ML, Nogueira M, Selores M, Lobo I. Reis J, et al. Among authors: nogueira m. Acta Med Port. 2021 Nov 2;34(11):799-800. doi: 10.20344/amp.15568. Epub 2021 Sep 13. Acta Med Port. 2021. PMID: 34520343 Free article. No abstract available.

4

Pemphigus foliaceous after mRNA COVID-19 vaccine.

Reis J, Nogueira M, Figueiras O, Coelho A, Cunha Velho G, Raposo I. Reis J, et al. Among authors: nogueira m. Eur J Dermatol. 2022 May 1;32(3):428-429. doi: 10.1684/ejd.2022.4294. Eur J Dermatol. 2022. PMID: 36065555 Free PMC article. No abstract available.

5

Psoriasis, biologic therapy, and the pandemic of the 21st century.

Nogueira M, Vender R, Torres T. Nogueira M, et al. Drugs Context. 2020 May 14;9:2020-4-10. doi: 10.7573/dic.2020-4-10. eCollection 2020. Drugs Context. 2020. PMID: 32477419 Free PMC article.

6

Alemtuzumab as first- and second-line treatment in patients with Sézary syndrome-The experience of a tertiary centre.

Nogueira M, Lau C, Teixeira MDA, Peixeiro R, Cabral R, Fernandes I. Nogueira M, et al. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e86-e88. doi: 10.1111/jdv.19441. Epub 2023 Aug 25. J Eur Acad Dermatol Venereol. 2024. PMID: 37595960 No abstract available.

7

Targeted Therapy for Pediatric Psoriasis.

Nogueira M, Paller AS, Torres T. Nogueira M, et al. Paediatr Drugs. 2021 May;23(3):203-212. doi: 10.1007/s40272-021-00443-5. Epub 2021 Apr 3. Paediatr Drugs. 2021. PMID: 33811318 Review.

8

Calling on dermatology to save a life: a case of MPO-ANCA-associated vasculitis.

Nogueira M, Machado Á, Coelho A, Raposo I. Nogueira M, et al. Eur J Dermatol. 2021 Dec 1;31(6):852-853. doi: 10.1684/ejd.2021.4188. Eur J Dermatol. 2021. PMID: 35107078 No abstract available.

9

Risk of tuberculosis reactivation with interleukin (IL)-17 and IL-23 inhibitors in psoriasis - time for a paradigm change.

Nogueira M, Warren RB, Torres T. Nogueira M, et al. J Eur Acad Dermatol Venereol. 2021 Apr;35(4):824-834. doi: 10.1111/jdv.16866. Epub 2020 Sep 1. J Eur Acad Dermatol Venereol. 2021. PMID: 32790003 Review.

10

Role of dupilumab in pediatric prurigo nodularis: Beyond the skin.

Oliveira J, Nogueira M, Pinto D, Machado S, Araújo AR, Teixeira F. Oliveira J, et al. Among authors: nogueira m. Pediatr Allergy Immunol. 2023 Jan;34(1):e13912. doi: 10.1111/pai.13912. Pediatr Allergy Immunol. 2023. PMID: 36705041 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,291 results

Search Page

Filters